|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, administrative and other expenses | |||||
| Depreciation and amortization | |||||
| Provision for doubtful accounts | |||||
| Restructuring and other costs | |||||
| Total operating expenses | |||||
| Non-operating (income) expense: | |||||
| Interest expense, net | |||||
| Pension settlement charge | |||||
| Other | |||||
| Total non-operating expenses | |||||
| Income before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income | |||||
| Continuing operations (in dollars per share) | |||||
| Diluted earnings (loss) per share (in dollars per share) | |||||
| Weighted average common shares outstanding (in shares) | |||||
| Dilutive effect of stock options and nonvested restricted stock awards (in shares) | |||||
| Weighted average common shares outstanding — assuming dilution (in shares) | |||||
Loading...